Phenotype-guided targeted therapy based on functional signal transduction pathway activity in recurrent ovarian cancer patients: The STAPOVER study protocol

Autor: van der Ploeg, Phyllis, Hendrikse, Cynthia SE., Thijs, Anna MJ., Westgeest, Hans M., Smedts, Huberdina PM., Vos, M Caroline, Jalving, Mathilde, Lok, Christianne AR., Boere, Ingrid A., van Ham, Maaike APC., Ottevanger, Petronella B., Westermann, Anneke M., Mom, Constantijne H., Lalisang, Roy I., Lambrechts, Sandrina, Bekkers, Ruud LM., Piek, Jurgen MJ.

Publikováno v: In Heliyon 15 January 2024 10(1)

Phenotype-guided targeted therapy based on functional signal transduction pathway activity in recurrent ovarian cancer patients: The STAPOVER study protocol.

Autor: van der Ploeg P; Department of Obstetrics and Gynaecology and Catharina Cancer Institute, Catharina Hospital, Eindhoven, the Netherlands.; GROW School for Oncology and Reproduction, Maastricht University, Maastricht, the Netherlands., Hendrikse CS; Department of Obstetrics and Gynaecology and Catharina Cancer Institute, Catharina Hospital, Eindhoven, the Netherlands.; GROW School for Oncology and Reproduction, Maastricht University, Maastricht, the Netherlands., Thijs AM; Department of Internal Medicine and Catharina Cancer Institute, Catharina Hospital, Eindhoven, the Netherlands., Westgeest HM; Department of Internal Medicine, Amphia Hospital, Breda, the Netherlands., Smedts HP; Department of Obstetrics and Gynaecology, Amphia Hospital, Breda, the Netherlands., Vos MC; Department of Obstetrics and Gynaecology, Elisabeth-Tweesteden Hospital, Tilburg, the Netherlands., Jalving M; Department of Medical Oncology, University Medical Centre Groningen, Groningen, the Netherlands., Lok CA; Department of Gynaecologic Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands., Boere IA; Department of Medical Oncology, Erasmus Medical Centre Cancer Institute, Rotterdam, the Netherlands., van Ham MA; Department of Obstetrics and Gynaecology, Radboud University Medical Centre, Nijmegen, the Netherlands., Ottevanger PB; Department of Oncology, Radboud University Medical Centre, Nijmegen, the Netherlands., Westermann AM; Department of Oncology, Amsterdam University Medical Centre, Amsterdam, the Netherlands., Mom CH; Department of Obstetrics and Gynaecology, Amsterdam University Medical Centre, Amsterdam, the Netherlands., Lalisang RI; Department of Medical Oncology, Maastricht University Medical Centre +, Maastricht, the Netherlands., Lambrechts S; Department of Obstetrics and Gynaecology, Maastricht University Medical Centre +, Maastricht, the Netherlands., Bekkers RL; Department of Obstetrics and Gynaecology and Catharina Cancer Institute, Catharina Hospital, Eindhoven, the Netherlands.; GROW School for Oncology and Reproduction, Maastricht University, Maastricht, the Netherlands., Piek JM; Department of Obstetrics and Gynaecology and Catharina Cancer Institute, Catharina Hospital, Eindhoven, the Netherlands.

Publikováno v: Heliyon [Heliyon] 2023 Dec 01; Vol. 10 (1), pp. e23170. Date of Electronic Publication: 2023 Dec 01 (Print Publication: 2024).

Repetitive electrostatic pressurised intraperitoneal aerosol chemotherapy (ePIPAC) with oxaliplatin as a palliative monotherapy for isolated unresectable colorectal peritoneal metastases: protocol of a Dutch, multicentre, open-label, single-arm, phase II study (CRC-PIPAC).

Autor: Rovers KP; Department of Surgery, Catharina Hospital, Eindhoven, The Netherlands., Lurvink RJ; Department of Surgery, Catharina Hospital, Eindhoven, The Netherlands., Wassenaar EC; Department of Surgery, Sint Antonius Hospital, Nieuwegein, The Netherlands., Kootstra TJ; Department of Surgery, Sint Antonius Hospital, Nieuwegein, The Netherlands., Scholten HJ; Department of Anaesthesiology, Catharina Hospital, Eindhoven, The Netherlands., Tajzai R; Department of Clinical Pharmacy, Catharina Hospital, Eindhoven, The Netherlands., Deenen MJ; Department of Clinical Pharmacy, Catharina Hospital, Eindhoven, The Netherlands., Nederend J; Department of Radiology, Catharina Hospital, Eindhoven, The Netherlands., Lahaye MJ; Department of Radiology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Huysentruyt CJ; Department of Pathology, Catharina Hospital, Eindhoven, The Netherlands., van 't Erve I; Department of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Fijneman RJ; Department of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Constantinides A; Imaging and Cancer, UMC Utrecht, Utrecht, The Netherlands., Kranenburg O; Imaging and Cancer, UMC Utrecht, Utrecht, The Netherlands., Los M; Department of Medical Oncology, Sint Antonius Hospital, Nieuwegein, The Netherlands., Thijs AM; Department of Medical Oncology, Catharina Hospital, Eindhoven, The Netherlands., Creemers GM; Department of Medical Oncology, Catharina Hospital, Eindhoven, The Netherlands., Burger JW; Department of Surgery, Catharina Hospital, Eindhoven, The Netherlands., Wiezer MJ; Department of Surgery, Sint Antonius Hospital, Nieuwegein, The Netherlands., Boerma D; Department of Surgery, Sint Antonius Hospital, Nieuwegein, The Netherlands., Nienhuijs SW; Department of Surgery, Catharina Hospital, Eindhoven, The Netherlands., de Hingh IH; Department of Surgery, Catharina Hospital, Eindhoven, The Netherlands.; GROW - School for Oncology and Development Biology, Maastricht University, Maastricht, Netherlands.

Publikováno v: BMJ open [BMJ Open] 2019 Jul 27; Vol. 9 (7), pp. e030408. Date of Electronic Publication: 2019 Jul 27.